日水製薬(株)の貸借残高詳細

主市場業種証券コード/EDINET英名称
東証PRM医薬品4550/E00971Nissui Pharmaceutical Co., Ltd
公表日公表担保貸付残高前週比借入残高（自己）前週比借入残高（転貸）前週比
2018/05/02日証協無担保0株0%0株0%114,021株-0.35%
2018/05/02日証協有担保31,800株+0.63%4,800株-7.69%21,600株+2.37%
2018/04/27日証協無担保0株0%0株0%114,421株-1.55%
2018/04/27日証協有担保31,600株-5.67%5,200株+6.12%21,100株-1.4%
2018/04/20日証協無担保0株0%0株0%116,221株+1.05%
2018/04/20日証協有担保33,500株+4.04%4,900株+2.08%21,400株+1.42%
2018/04/13日証協無担保0株0%0株0%115,011株+0.26%
2018/04/13日証協有担保32,200株+1.58%4,800株+4.35%21,100株-10.21%
2018/04/06日証協無担保0株0%0株0%114,714株+5354.78%
2018/04/06日証協有担保31,700株-31.97%4,600株+1433.33%23,500株-38.48%
2018/03/30日証協無担保0株-100%0株0%2,103株-98.03%
2018/03/30日証協有担保46,600株+4.25%300株-66.67%38,200株-7.06%
2018/03/23日証協無担保14,800株0%0株0%106,714株-7.86%
2018/03/23日証協有担保44,700株+7.71%900株-57.14%41,100株+13.54%
2018/03/16日証協無担保14,800株0%0株-100%115,814株-0.43%
2018/03/16日証協有担保41,500株+12.47%2,100株-60.38%36,200株+30.22%
2018/03/09日証協無担保14,800株0%2,100株0%116,314株+0.78%
2018/03/09日証協有担保36,900株-3.4%5,300株+6%27,800株-4.79%
2018/03/02日証協無担保14,800株0%2,100株0%115,413株+2.68%
2018/03/02日証協有担保38,200株-13.96%5,000株-1.96%29,200株-15.85%
2018/02/23日証協無担保14,800株0%2,100株0%112,403株+0.38%
2018/02/23日証協有担保44,400株-14.78%5,100株-1.92%34,700株+11.94%
2018/02/16日証協無担保14,800株0%2,100株0%111,972株+1.08%
2018/02/16日証協有担保52,100株+15.78%5,200株+1.96%31,000株-2.21%
2018/02/09日証協無担保14,800株0%2,100株-22.22%110,772株+2.4%
2018/02/09日証協有担保45,000株-2.81%5,100株0%31,700株+5.32%
2018/02/02日証協無担保14,800株-1.33%2,700株-3.57%108,172株+0.84%
2018/02/02日証協有担保46,300株+6.44%5,100株0%30,100株-0.33%
2018/01/26日証協無担保15,000株0%2,800株-3.45%107,271株-1.47%
2018/01/26日証協有担保43,500株+7.14%5,100株-1.92%30,200株+11.03%
2018/01/19日証協無担保15,000株+1.35%2,900株-6.45%108,868株-0.36%
2018/01/19日証協有担保40,600株+5.45%5,200株0%27,200株+10.12%
2018/01/12日証協無担保14,800株0%3,100株-88.93%109,258株+1.11%
2018/01/12日証協有担保38,500株+1.85%5,200株0%24,700株+2.49%
2018/01/05日証協無担保14,800株0%28,000株0%108,058株+0.47%
2018/01/05日証協有担保37,800株-9.35%5,200株0%24,100株+2.12%
2017/12/29日証協無担保14,800株0%28,000株+1020%107,557株+0.38%
2017/12/29日証協有担保41,700株+15.83%5,200株0%23,600株+2.16%

※株式分割は考慮していませんのでご注意ください。

Page Top